Nicorette Fruit (Nicotine)

Nicotine, the active ingredient in Nicorette Fruit, is a nicotine replacement therapy presented as an oromucosal formulation for oromucosal use. It treats nicotine dependence and aids smoking cessation in adult smokers. GNH USA supplies Nicorette Fruit as a licensed, GDP-compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Nicorette Fruit is a nicotine replacement product used to manage nicotine dependence and support cessation of tobacco use. - Smoking cessation: Helps adult smokers reduce cravings and withdraw from nicotine. - Nicotine dependence: Provides controlled nicotine to ease withdrawal symptoms. - Relapse prevention: Supports individuals who have quit smoking to maintain abstinence.

Nicorette Fruit may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Mouth irritation: mild soreness or tingling in the oral cavity. - Hiccups: brief episodes of involuntary diaphragm contraction. - Nausea: feeling of queasiness after use. - Throat irritation: discomfort or scratchy sensation. - Dyspepsia: indigestion or upset stomach. - Increased salivation: excess saliva production.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Chest pain: unexpected discomfort in the chest area. - Irregular heartbeat: palpitations or arrhythmia. - Severe dizziness: pronounced vertigo or loss of balance. - Anaphylaxis: life‑threatening systemic allergic response.

When using Nicorette Fruit, certain precautions should be observed to ensure safety and effectiveness. - Medical assessment: evaluate cardiovascular status before initiating therapy. - Pregnancy and lactation: consult a healthcare professional before use. - Concurrent nicotine products: avoid using other nicotine sources while on therapy. - Age restriction: not intended for use in children. - Storage: Store below 25°C: keep in the original pack, protect from moisture and heat.

Nicotine may interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): additive cardiovascular stimulation. - Beta‑blockers: nicotine‑induced tachycardia may counteract beta‑blocker effects.

Moderate Interactions (Monitor Closely): - Caffeine: increased stimulation and possible jitteriness. - Alcohol: enhanced nicotine effects and potential for increased side effects. - Antidepressants (SSRIs): possible alteration of nicotine metabolism.